We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




NMR-on-a-Chip's Magnetic Mini-Sensor Has Applications in Drug Development

By Biotechdaily staff writers
Posted on 10 Mar 2008
A super-sensitive mini-sensor can detect nuclear magnetic resonance (NMR) in tiny samples of fluids flowing through a novel microchip. More...
The prototype chip device may have wide application as a sensitive chemical analyzer, for example, in rapid screening to find new drugs.

The technology was developed in collaboration between U.S. National Institute of Standards and Technology (NIST; Gaithersburg, MD, USA) and the University of California, Berkeley (CA, USA), and was described in the February 6, 2008 online issue of the Proceedings of the [U.S.] National Academy of Sciences (PNAS). The NMR chip detected magnetic signals from atomic nuclei in tap water flowing through a custom silicon chip that juxtaposes a tiny fluid channel and the NIST sensor. The Berkeley group recently co-developed this "remote NMR” technique for tracking small volumes of fluid or gas flow inside soft materials such as biologic tissue or porous rock, for possible applications in industrial processes and oil exploration. The chip could be used in NMR spectroscopy, a widely used technique for determining physical, chemical, electronic, and structural information about molecules. NMR signals are equivalent to those detected in magnetic resonance imaging (MRI) systems

Berkeley scientists selected the NIST sensor, a type of atomic magnetometer, for the chip device because of its small size and high sensitivity, which make it possible to detect weak magnetic resonance signals from a small sample of atoms in the adjacent microchannel. Detection is most effective when the sensor and sample are about the same size and located close together, according to lead author of the study, Dr. Micah Ledbetter. Thus, when samples are tiny, as in economic screening of many chemicals, a small sensor is crucial, according to Dr. Ledbetter.

Its small size and extreme sensitivity make the NIST sensor suitable for the microchip device, in contrast to SQUIDs (superconducting quantum interference devices) that require bulky equipment for cooling to cryogenic temperatures or conventional copper coils that need much higher magnetic fields (typically generated by large, superconducting magnets) such as those in conventional MRI.

The results reported in the PNAS demonstrated another use for the NIST mini-sensor, a spin-off of NIST's miniature atomic clocks. The sensor already has been shown to have biomedical imaging applications.

The lead investigator for the study was Dr. Alexander Pines, a leading authority on NMR. A joint university/NIST patent application is being filed for the microchip device.


Related Links:
National Institute of Standards and Technology
University of California, Berkeley

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.